Skip to main content
. 2007 Mar 19;133(1):13–19. doi: 10.1016/j.virusres.2007.02.014

Table 1.

Significantly expressed cytokines and chemokines during SARS clinical evolutiona

Expression Early (acute) SARS Late SARS
Non-severe SARS Increased IFN-α, IFN-γ, CXCL10, IL-8 CXCL10, IL-8
Severe SARS Increased IFN-α, IFN-γ, CXCL10 IL-8, CXCL10b, CCL2b
Decreased IL-12p70, IL-2, TNF-α IL-12p70b, IL-2, TNF-αb, IFN-γ
a

Compared to healthy controls (P < 0.05).

b

Also significantly different compared to non-severe SARS patients (P < 0.05).